Neither regulators nor police have attacked illegal production, promotion, and sale with sufficient vigor, perhaps because ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Almost 1,200 people in Kern County have died from fentanyl overdoses since 2018, including 171 in 2024 and an all-time high of 294 the year before, according to updated numbers from the Kern ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The unprecedented increase in drug overdose deaths in the United States, long believed to be driven by access to legal and ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.